265 related articles for article (PubMed ID: 20716594)
1. Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience.
Alapetite C; Brisse H; Patte C; Raquin MA; Gaboriaud G; Carrie C; Habrand JL; Thiesse P; Cuilliere JC; Bernier V; Ben-Hassel M; Frappaz D; Baranzelli MC; Bouffet E
Neuro Oncol; 2010 Dec; 12(12):1318-25. PubMed ID: 20716594
[TBL] [Abstract][Full Text] [Related]
2. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease.
Calaminus G; Kortmann R; Worch J; Nicholson JC; Alapetite C; Garrè ML; Patte C; Ricardi U; Saran F; Frappaz D
Neuro Oncol; 2013 Jun; 15(6):788-96. PubMed ID: 23460321
[TBL] [Abstract][Full Text] [Related]
3. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
[TBL] [Abstract][Full Text] [Related]
6. Relapsing intracranial germ cell tumours warrant retreatment.
Callec L; Lardy-Cleaud A; Guerrini-Rousseau L; Alapetite C; Vignon L; Chastagner P; Frappaz D; Faure-Conter C
Eur J Cancer; 2020 Sep; 136():186-194. PubMed ID: 32711377
[TBL] [Abstract][Full Text] [Related]
7. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
[TBL] [Abstract][Full Text] [Related]
8. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
9. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy with autologous stem cell transplantation spares re-irradiation for recurrent intracranial germinoma.
Kubota H; Umeda K; Kagehiro K; Tanaka K; Daifu T; Hamabata T; Nodomi S; Kato I; Hiramatsu H; Arakawa Y; Mizowaki T; Adachi S
Pediatr Blood Cancer; 2018 Aug; 65(8):e27104. PubMed ID: 29693779
[TBL] [Abstract][Full Text] [Related]
11. Comparison between Craniospinal Irradiation and Limited-Field Radiation in Patients with Non-metastatic Bifocal Germinoma.
Li B; Lv W; Li C; Yang J; Chen J; Feng J; Chen L; Ma Z; Li Y; Wang J; Liu Y; Li Y; Liu S; Luo S; Qiu X
Cancer Res Treat; 2020 Oct; 52(4):1050-1058. PubMed ID: 32646203
[TBL] [Abstract][Full Text] [Related]
12. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
13. An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. Société Française d'Oncologie Pédiatrique.
Baranzelli MC; Patte C; Bouffet E; Portas M; Mechinaud-Lacroix F; Sariban E; Roche H; Kalifa C
J Neurooncol; 1998 May; 37(3):229-39. PubMed ID: 9524081
[TBL] [Abstract][Full Text] [Related]
14. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma.
Sawamura Y; Shirato H; Ikeda J; Tada M; Ishii N; Kato T; Abe H; Fujieda K
J Neurosurg; 1998 Jan; 88(1):66-72. PubMed ID: 9420074
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy for relapsed CNS germinoma after primary chemotherapy.
Merchant TE; Davis BJ; Sheldon JM; Leibel SA
J Clin Oncol; 1998 Jan; 16(1):204-9. PubMed ID: 9440744
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
[TBL] [Abstract][Full Text] [Related]
18. Time to dismiss boost? Outcomes of children with localized and metastatic germinoma.
Foo JC; Yaman Bajin I; Marushchak O; McKeown T; Bouffet E; Tsang DS; Laperriere N; Dirks P; Drake J; Ertl-Wagner B; Bartels U
J Neurooncol; 2023 Apr; 162(2):443-448. PubMed ID: 37039951
[TBL] [Abstract][Full Text] [Related]
19. [Cerebral germ cell tumors in adults. A retrospective study of 19 cases].
Agranat P; Jedynak P; Epardeau B; Extra JM; Mignot L
Bull Cancer; 1995 Aug; 82(8):650-9. PubMed ID: 7492821
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the Management of Childhood Intracranial Germ Cell Tumors in Middle-Income Countries: A 20-Year Retrospective Review From a Single Tertiary Center in Malaysia.
Rajagopal R; Leong SH; Jawin V; Foo JC; Ahmad Bahuri NF; Mun KS; Azman RR; Loh J; Yap TY; Ariffin H; Moreira DC; Gottardo NG; Bouffet E; Ganesan D
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e913-e923. PubMed ID: 33633029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
